Product info

HSA/FSA EligibleDrawtex is a hydroconductive wound dressing with LevaFiber Technology. LevaFiber is a combination of two types of absorbent cross-action structures that creates the ability to draw exudate away from the wound surface.Drawtex tracheostomy dressing is designed specifically for application around a tracheostomy tube after tracheostomy surgery. The keyhole aperture in the dressing allows it to fit neatly around a tracheostomy tube or other drain or stoma to collect fluid and excretions from the tracheostomy site.Drawtex facilitates effective wound bed preparation.Wound bed preparation is the management of a wound in order to accelerate endogenous healing or to facilitate the effectiveness of other therapeutic measures. Recent data have been published showing how wound treatment with Drawtex assists with the complex challenges of wound bed preparation.Facilitates removal of debris: Using an advanced pattern recognition software algorithm to analyze digital wound images, researchers calculated wound measurements and analyzed tissue composition of the wound bed. They found: Drawtex actively draws fluid away from the wound up to 150cc/hour, retaining its integrity when moist. Drawtex helps to remove debris from the wound by drawing out fibrin and slough, while leaving healthy granulation tissue in place.Draws and absorbs excessive wound exudate: Another study concluded that the advantages of exudate removal by Drawtex were numerous. Not only was the fluid removed, but nutrients in the exudate that facilitate biofilm production were also drawn off.Draws bacteria from the wound: A study that evaluated Drawtex in an infected burn model demonstrated that Drawtex can draw methicillin-resistant Staphylococcus aureus (MRSA) from either an inoculated broth or an experimental burn wound eschar. Similar results were reported in patients with chronic wounds, where tissue biopsy bacterial counts decreased from 106 to 102 CFUs per gram of tissue, while at the same time the bacterial counts in the Drawtex dressings increased up to 104 CFUs.Draws harmful MMPs from the wound: Chronic wounds have excessive inflammation, increased pro-inflammatory cytokines, increased proteases such as MMPs, and decreased growth factors. Removing or decreasing the harmful MMPs is an important aspect of wound bed preparation. One study reported that Drawtex could draw MMP-9 and transport it for a distance up to 7cm from the wound. Another similar study showed that both MMP-9 and MMP-1 were drawn out of chronic wounds with Drawtex wound dressings, with a concomitant rise in MMPs in the Drawtex dressings.Sets the stage for endogenous healing or wound closure procedures: With Drawtex meeting the goals listed above for wound bed preparation, obstacles to endogenous wound healing or wound closure procedures are reduced.Drawtex facilitates removal of wound debries.Drawtex draws exudate, Bacteria and harmful MMPs.Drawtex sets the stage for endogenous healing or wound closure procedures.Drawtex combines 3 mechanisms of action of differentiate it form other standard dressings.Drawtex is indicated for wounds with moderate to high levels of exudate including: Acute wounds - complex surgical wounds, burns. Chronic wounds - Leg ulcers, diabetic foot ulcers, pressure ulcers (stage 2-4).This item is FSA (Flexible Spending Account) eligible.

Price History